Gamida Cell Ltd. Ordinary Shares
GMDA
GMDA was delisted on the 5th of April, 2024.
12 hedge funds and large institutions have $23.7M invested in Gamida Cell Ltd. Ordinary Shares in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
6% less capital invested
Capital invested by funds: $25.1M → $23.7M (-$1.41M)
8% less funds holding
Funds holding: 13 → 12 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$31K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$591K |
| 2 |
NC
Noked Capital
Tel Aviv,
Israel
|
-$237K |
| 3 |
NI
Noked Israel
Ramat Hasharon,
Israel
|
-$237K |
| 4 |
Millennium Management
New York
|
-$163K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$59.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $12.4M | – | – | – |
|
|
BI
2
BVF Inc
San Francisco,
California
| $4.3M | – | – | – |
|
|
RSCM
3
Rock Springs Capital Management
Baltimore,
Maryland
| $4.3M | – | – | – |
|
|
MIH
4
Meitav Investment House
Bene-Beraq,
Israel
| $962K | -$6.43K | -1,351 | -0.6% |
|
|
5
Alyeska Investment Group
Chicago,
Illinois
| $723K | -$59.8K | -12,563 | -7% |
|
|
DCM
6
DAFNA Capital Management
Los Angeles,
California
| $640K | -$591K | -124,128 | -45% |
|
|
7
Millennium Management
New York
| $150K | -$163K | -34,180 | -49% |
|
|
PF
8
Phoenix Financial
Givatayim,
Israel
| $125K | – | – | – |
|
|
EDRH
9
Edmond de Rothschild Holding
Chambesy,
Switzerland
| $63K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $28K | +$31K | +6,509 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $6K | +$3.5K | +735 | +112% |
|
12
Victory Capital Management
San Antonio,
Texas
| $4K | – | – | – |
|
|
NC
13
Noked Capital
Tel Aviv,
Israel
| – | -$237K | -54,630 | Closed |
|
|
NI
14
Noked Israel
Ramat Hasharon,
Israel
| – | -$237K | -54,630 | Closed |
|
GMDA Hedge Fund Activity: Q4 2019 in Review
12 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q4 2019, worth a combined $23.7M — down 5.6% from $25.1M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of GMDA and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, opening a new position worth an estimated $31K. The largest seller was DAFNA Capital Management, cutting an estimated $591K.
- 12 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q4 2019, down from 13 in Q3 2019.
- Funds reported $23.7M of Gamida Cell Ltd. Ordinary Shares stock for Q4 2019, down 5.6% quarter-over-quarter.
- 1 fund opened new Gamida Cell Ltd. Ordinary Shares positions in Q4 2019 and 2 closed out, a net change of -1 holder.
- The largest Gamida Cell Ltd. Ordinary Shares buyer in Q4 2019 was UBS Group, an estimated $31K added.
- The largest Gamida Cell Ltd. Ordinary Shares seller in Q4 2019 was DAFNA Capital Management, an estimated $591K sold.
Based on aggregated 13F filings for Q4 2019.